Levi & Korsinsky, LLP

Levi & Korsinsky, LLP

RDY shares fell approximately 9% after Q1 FY27 results showed a 5.66% year-over-year revenue decline and a 68.7% profit decline. The investigation focuses on investor losses tied to the market reaction to the earnings miss.

NEW YORK, July 24, 2026 /PRNewswire/ -- July 22, 2026 brought a roughly 9% drop in Dr. Reddy's Laboratories (NYSE: RDY) shares after the Company reported Q1 FY27 results showing a year-over-year revenue decline and sharply lower profit. If RDY losses hit your account after the earnings release, you are encouraged to act now. Investors who lost money on RDY may report your RDY loss now . You may also contact Joseph E. Levi, Esq. by telephone at (212) 363-7500.

Originally published on the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.